JPMorgan offers Uncapped Buffered Notes Linked to S&P Futures
JPMorgan Chase Financial Company LLC is offering uncapped buffered return enhanced notes linked to the S&P 500® Futures Excess Return Index due April 1, 2031 that provide at least a 1.88 upside leverage factor and a 20.00 buffer.
JPMorgan Chase Financial Company LLC is offering uncapped buffered return enhanced notes linked to the S&P 500® Futures Excess Return Index due April 1, 2031 that provide at least a 1.88 upside leverage factor and a 20.00 buffer. The notes are sold in minimum denominations of $1,000 per note and are unsecured obligations of JPMorgan Chase Financial, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes are designed to return $1,000 + ($1,000 × Index Return × Upside Leverage Factor) at maturity if the Final Value exceeds the Initial Value; if the Final Value declines by more than the 20.00 buffer, investors lose 1% of principal for each 1% below the buffer, up to an 80.00 potential principal loss. The pricing date is on or about March 27, 2026 and settlement is on or about April 1, 2026. The estimated value at pricing example shown is approximately $982.20 per $1,000 note and the pricing supplement reserves a minimum estimated value of $900.00 per $1,000 note.
Positive
- None.
Negative
- None.
Insights
Product blends leveraged upside with a fixed downside buffer tied to S&P 500 futures.
The notes provide an at least 1.88 upside multiplier above any index appreciation and a 20.00 buffered downside that preserves principal only if losses are within that buffer. Payment mechanics are formulaic: gains are multiplied by the Upside Leverage Factor; losses beyond the buffer reduce principal one-for-one.
Primary dependencies include the SPX Futures Index closing on the Pricing Date and Observation Date, the issuer and guarantor credit quality, and futures roll and negative roll returns. Subsequent disclosures at pricing will state the final Upside Leverage Factor and the confirmed estimated value; timing is tied to the Pricing Date on or about March 27, 2026.
Tax treatment is expected but not assured; IRS treatment could alter character and timing of income.
The issuer expects to treat the notes as open transactions not treated as debt for U.S. federal income tax purposes, which would generally yield long-term capital gain/loss treatment if held over one year. That treatment is contingent on special tax counsel confirmation at pricing and is not binding on the IRS or courts.
Section 871(m) analysis is addressed: the issuer expects 871(m) will not apply for Non-U.S. Holders based on determinations made, but the IRS may disagree. Holders should obtain individualized tax advice before investing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What do JPMorgan (AMJB) Uncapped Buffered Return Enhanced Notes pay at maturity?
How much principal can I lose on the AMJB notes?
What are the key dates for these JPMorgan notes (AMJB)?
Who bears credit risk for the AMJB notes?
Will these AMJB notes pay periodic interest?
AI-generated analysis. How Rhea-AI works. Not financial advice.